Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer

被引:119
|
作者
Healy, L. A. [1 ,2 ]
Ryan, A. M. [1 ,2 ]
Carroll, P. [2 ,3 ]
Ennis, D. [2 ,3 ]
Crowley, V. [2 ,4 ]
Boyle, T. [2 ,3 ]
Kennedy, M. J. [2 ,5 ]
Connolly, E. [2 ,3 ]
Reynolds, J. V. [2 ,3 ]
机构
[1] St James Hosp, Dept Clin Nutr, Dublin 8, Ireland
[2] Univ Dublin Trinity Coll, Dublin 2, Ireland
[3] St James Hosp, Dept Surg, Dublin 8, Ireland
[4] St James Hosp, Dept Clin Chem, Dublin 8, Ireland
[5] St James Hosp, Acad Unit Clin & Med Oncol, Dublin 8, Ireland
关键词
Breast cancer; metabolic syndrome; obesity; postmenopausal; tumour pathology; BODY-MASS INDEX; RECEPTOR EXPRESSION; SEX-HORMONES; RISK-FACTOR; C-PEPTIDE; WOMEN; SIZE; POPULATION; PREVALENCE; MORTALITY;
D O I
10.1016/j.clon.2010.02.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Obesity is associated with both an increased risk of postmenopausal breast cancer and increased mortality rates. The mechanism is unclear, and central (visceral) obesity, insulin resistance, altered sex steroids and altered adipokines are mooted as possible factors. These features may cluster in the so-called metabolic syndrome. The relevance of metabolic syndrome to the biology of breast cancer is unknown, and this was the focus of the present study. Materials and methods: All postmenopausal women with newly diagnosed breast cancer (n = 105) were recruited. A detailed clinical history was carried out, as well as a body composition analysis, metabolic screen and measurement of adipokines and inflammatory markers. Results: The median age was 68 years (40-94 years) and the mean body mass index was 28.3 +/- 5.2 kg/m(2), with 87% of patients centrally obese. Metabolic syndrome was diagnosed in 39% of patients, and was significantly associated with central obesity (P < 0.005) and increased inflammation, with C-reactive protein levels doubling in metabolic syndrome patients compared with non-metabolic syndrome patients (10.3 vs 5.8 mg/l; P = 0.084). Patients with a later pathological stage (II-IV) were significantly more likely to be obese (P = 0.007), centrally obese (P = 0.009), hyperglycaemic (P = 0.047) and hyperinsulinaemic (P = 0.026); 51% had metabolic syndrome compared with 12% for early stage disease. Patients with node-positive disease were significantly more likely to be hyperinsulaemic (P = 0.030) and have metabolic syndrome (P = 0.028) than patients with node-negative disease. Discussion: The data suggest that metabolic syndrome and central obesity are common in postmenopausal breast cancer patients, and that metabolic syndrome may be associated with a more aggressive tumour biology. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 50 条
  • [21] A clinically confirmed family history for early myocardial infarction is associated with increased risk of obesity, insulin resistance and metabolic syndrome
    Magnusson, Martin
    Burri, Philippe
    Melander, Olle
    JOURNAL OF HYPERTENSION, 2012, 30 (05) : 948 - 953
  • [22] Metabolic syndrome, insulin resistance, and inflammation in breast cancer: Impact on prognosis and adjuvant interventions
    Goodwin P.J.
    Current Breast Cancer Reports, 2010, 2 (4) : 182 - 189
  • [23] Effect of Abdominal Obesity on Insulin Resistance and the Components of the Metabolic Syndrome: Evidence Supporting Obesity as the Central Feature
    Çavlan Türkoglu
    Belgin Süsleyici Duman
    Demet Günay
    Penbe Çagatay
    Remzi Özcan
    A Sevim Büyükdevrim
    Obesity Surgery, 2003, 13 : 699 - 705
  • [24] Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome:: Evidence supporting obesity as the central feature
    Türkoglu, C
    Duman, BS
    Günay, D
    Çagatay, P
    Özcan, R
    Büyükdevrim, AS
    OBESITY SURGERY, 2003, 13 (05) : 699 - 705
  • [25] Normal Weight Obesity Is Associated with Metabolic Syndrome and Insulin Resistance in Young Adults from a Middle-Income Country
    Madeira, Francilene B.
    Silva, Antonio A.
    Veloso, Helma F.
    Goldani, Marcelo Z.
    Kac, Gilberto
    Cardoso, Viviane C.
    Bettiol, Heloisa
    Barbieri, Marco A.
    PLOS ONE, 2013, 8 (03):
  • [26] Screening Survivors of Childhood Acute Lymphoblastic Leukemia for Obesity, Metabolic Syndrome, and Insulin Resistance
    Karakurt, Hasan
    Sarper, Nazan
    Kilic, Suar Caki
    Gelen, Sema Aylan
    Zengin, Emine
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2012, 29 (06) : 551 - 561
  • [27] Insulin Resistance and the Metabolic Syndrome in Obese Children Referred to an Obesity Center
    Rotteveel, J.
    Felius, A.
    van Weissenbruch, M. M.
    Delemarre-Van de Waal, H. A.
    Rotteveel, J.
    Felius, A.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2010, 23 (09) : 943 - 951
  • [28] Metabolic Syndrome and Insulin Resistance in Subjects with Morbid Obesity
    Soverini, Valentina
    Moscatiello, Simona
    Villanova, Nicola
    Ragni, Elisabetta
    Di Domizio, Silvia
    Marchesini, Giulio
    OBESITY SURGERY, 2010, 20 (03) : 295 - 301
  • [29] Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort
    Reeves, Katherine W.
    McLaughlin, Vicki
    Fredman, Lisa
    Ensrud, Kristine
    Cauley, Jane A.
    CANCER CAUSES & CONTROL, 2012, 23 (08) : 1241 - 1251
  • [30] Early menarche is associated with metabolic syndrome and insulin resistance in premenopausal Korean women
    Lim, Se Won
    Ahn, Ju Hyun
    Lee, Jun Ah
    Kim, Dong Ho
    Seo, Ju-Hee
    Lim, Jung Sub
    EUROPEAN JOURNAL OF PEDIATRICS, 2016, 175 (01) : 97 - 104